Each filer's latest filing for 00847X104 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Farallon Capital Management, L.L.C.
13G/A
|
9.9% |
8/3/2026
Event 6/30/2026
|
||
| Farallon Capital Management, L.L.C. | 9.9% | |||
| Farallon Capital Partners, L.P. | 0% | |||
| Farallon Capital Institutional Partners, L.P. | 0% | |||
| Farallon Capital Institutional Partners II, L.P. | 0% | |||
| Farallon Capital Institutional Partners III, L.P. | 0% | |||
| Four Crossings Institutional Partners V, L.P. | 0% | |||
| Farallon Capital Offshore Investors II, L.P. | 0% | |||
| Farallon Capital (AM) Investors, L.P. | 0% | |||
| Farallon Capital F5 Master I, L.P. | 0% | |||
| Farallon Healthcare Partners Master, L.P. | 0% | |||
| Farallon Partners, L.L.C. | 0% | |||
| Farallon Institutional (GP) V, L.L.C. | 0% | |||
| Farallon F5 (GP), L.L.C. | 0% | |||
| Farallon Healthcare Partners (GP), L.L.C. | 0% | |||
| Dapice Joshua J. | 9.9% | |||
| Dreyfuss, Philip D. | 9.9% | |||
| Dunn Hannah E. | 9.9% | |||
| Gehani, Varun N. | 9.9% | |||
| Giauque, Nicolas | 9.9% | |||
| Husen, Avner A. | 9.9% | |||
| Kim, David T. | 9.9% | |||
| Linn, Michael G. | 9.9% | |||
| Luo Patrick (Cheng) | 9.9% | |||
| Roberts, Jr., Thomas G. | 9.9% | |||
| Saito Edric C. | 9.9% | |||
| Short Daniel S. | 9.9% | |||
| Spokes, Andrew J. M. | 9.9% | |||
| Warren, John R. | 9.9% | |||
| Wehrly, Mark C. | 9.9% | |||
|
Farallon Capital Partners, L.P.
13G/A
|
8.8% |
2/9/2026
Event 12/31/2025
|
||
| Farallon Capital Partners, L.P. | 0.7% | |||
| Farallon Capital Institutional Partners, L.P. | 0.8% | |||
| Farallon Capital Institutional Partners II, L.P. | 0.2% | |||
| Farallon Capital Institutional Partners III, L.P. | 0.1% | |||
| Four Crossings Institutional Partners V, L.P. | 0.2% | |||
| Farallon Capital Offshore Investors II, L.P. | 1.6% | |||
| Farallon Capital (AM) Investors, L.P. | 0.1% | |||
| Farallon Capital F5 Master I, L.P. | 0.2% | |||
| Farallon Healthcare Partners Master, L.P. | 5.0% | |||
| Farallon Partners, L.L.C. | 8.7% | |||
| Farallon Institutional (GP) V, L.L.C. | 0.2% | |||
| Farallon F5 (GP), L.L.C. | 0.2% | |||
| Farallon Healthcare Partners (GP), L.L.C. | 5.0% | |||
| Dapice Joshua J. | 8.8% | |||
| Dreyfuss, Philip D. | 8.8% | |||
| Dunn Hannah E. | 8.8% | |||
| Fried, Richard B | 0% | |||
| Gehani, Varun N. | 8.8% | |||
| Giauque, Nicolas | 8.8% | |||
| Husen, Avner A. | 8.8% | |||
| Kim, David T. | 8.8% | |||
| Linn, Michael G. | 8.8% | |||
| Luo Patrick (Cheng) | 8.8% | |||
| Patel, Rajiv A. | 0% | |||
| Roberts, Jr., Thomas G. | 8.8% | |||
| Saito Edric C. | 8.8% | |||
| Seybold, William | 0% | |||
| Short Daniel S. | 8.8% | |||
| Spokes, Andrew J. M. | 8.8% | |||
| Warren, John R. | 8.8% | |||
| Wehrly, Mark C. | 8.8% | |||
| BlackRock, Inc. 13G/A | 7.8% |
7/17/2025
Event 6/30/2025
|
||
|
D. E. Shaw & Co., L.P.
13G/A
|
6.5% |
11/16/2026
Event 9/30/2026
|
||
| D. E. Shaw & Co., L.P. | 6.5% | |||
| David E. Shaw | 6.5% | |||
| Morgan Stanley 13G | 5.7% |
11/13/2026
Event 9/30/2026
|
||
| State Street Corp 13G | 5.3% |
2/9/2026
Event 12/31/2025
|
||
| Vanguard Capital Management LLC 13G | 5.3% |
4/29/2026
Event 3/31/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (6) | ||||
|
Paradigm Biocapital Advisors LP
13G/A
|
4.9% |
11/14/2025
Event 9/30/2025
|
||
| Paradigm BioCapital Advisors LP | 4.9% | |||
| Paradigm BioCapital Advisors GP LLC | 4.9% | |||
| Senai Asefaw, M.D. | 4.9% | |||
| Paradigm BioCapital International Fund Ltd. | 4.4% | |||
|
Armistice Capital, LLC
13G/A
|
4.6% |
5/15/2026
Event 3/31/2026
|
||
| Armistice Capital, LLC | 4.6% | |||
| Steven Boyd | 4.6% | |||
|
Lynx1 Capital Management LP
13G/A
|
0.8% |
11/16/2026
Event 9/30/2026
|
||
| Lynx1 Capital Management LP | 0.8% | |||
| Weston Nichols | 0.8% | |||
|
BB Biotech AG
13G/A
|
0% |
6/13/2025
Event 6/1/2025
|
||
| BB Biotech AG | 0% | |||
| Biotech Target N.V. | 0% | |||
|
Bellevue Group AG
13G/A
|
0% |
12/5/2025
Event 11/19/2025
|
||
| Bellevue Group AG | 0% | |||
| Bellevue Asset Management AG | 0% | |||
| Vanguard Group Inc 13G/A | 0% |
3/26/2026
Event 3/13/2026
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 244 | 67.3 M | $2.24B |
| 2026 Q2 | 239 | 66.0 M | $2.45B |
| 2026 Q1 | 238 | 63.1 M | $2.12B |
| 2025 Q4 | 241 | 61.3 M | $1.67B |
| 2025 Q3 | 228 | 63.5 M | $2.55B |
| 2025 Q2 | 219 | 61.7 M | $2.05B |
| 2025 Q1 | 223 | 60.1 M | $1.76B |
| 2024 Q4 | 229 | 59.8 M | $1.97B |
| 2024 Q3 | 213 | 58.1 M | $2.58B |
| 2024 Q2 | 210 | 58.2 M | $2.51B |
| 2024 Q1 | 192 | 62.0 M | $1.81B |
| 2023 Q4 | 172 | 59.9 M | $1.33B |
| 2023 Q3 | 151 | 59.1 M | $1.46B |
| 2023 Q2 | 156 | 59.4 M | $1.68B |
| 2023 Q1 | 167 | 59.0 M | $1.36B |
| 2022 Q4 | 165 | 59.5 M | $1.67B |
| 2022 Q3 | 171 | 58.0 M | $1.64B |
| 2022 Q2 | 159 | 59.0 M | $1.31B |
| 2022 Q1 | 162 | 59.9 M | $1.74B |
| 2021 Q4 | 165 | 59.2 M | $1.95B |
| 2021 Q3 | 169 | 60.9 M | $2.81B |
| 2021 Q2 | 191 | 65.9 M | $3.63B |
| 2021 Q1 | 182 | 65.3 M | $3.37B |
| 2020 Q4 | 206 | 65.0 M | $2.82B |
| 2020 Q3 | 218 | 65.9 M | $2.30B |
| 2020 Q2 | 220 | 67.5 M | $3.61B |
| 2020 Q1 | 202 | 69.4 M | $2.47B |
| 2019 Q4 | 205 | 69.0 M | $3.30B |
| 2019 Q3 | 192 | 61.9 M | $2.01B |
| 2019 Q2 | 193 | 60.8 M | $3.03B |
| 2019 Q1 | 207 | 60.1 M | $4.06B |
| 2018 Q4 | 200 | 58.1 M | $2.68B |
| 2018 Q3 | 213 | 56.0 M | $4.32B |
| 2018 Q2 | 220 | 54.9 M | $4.63B |
| 2018 Q1 | 200 | 54.9 M | $4.48B |
| 2017 Q4 | 181 | 47.0 M | $2.69B |
| 2017 Q3 | 174 | 46.1 M | $3.07B |
| 2017 Q2 | 171 | 46.2 M | $2.37B |
| 2017 Q1 | 160 | 41.0 M | $2.39B |
| 2016 Q4 | 165 | 39.1 M | $1.63B |
| 2016 Q3 | 165 | 37.9 M | $2.00B |
| 2016 Q2 | 158 | 34.1 M | $1.42B |
| 2016 Q1 | 159 | 33.8 M | $1.37B |
| 2015 Q4 | 145 | 33.0 M | $2.14B |
| 2015 Q3 | 153 | 31.4 M | $2.22B |
| 2015 Q2 | 162 | 30.1 M | $3.35B |
| 2015 Q1 | 152 | 28.0 M | $2.64B |
| 2014 Q4 | 145 | 27.7 M | $3.10B |
| 2014 Q3 | 120 | 24.5 M | $1.50B |
| 2014 Q2 | 99 | 23.6 M | $1.08B |
| 2014 Q1 | 75 | 20.5 M | $804M |